Trials / Conditions / Metastatic Malignant Neoplasm in the Central Nervous System

Metastatic Malignant Neoplasm in the Central Nervous System

7 registered clinical trials studyying Metastatic Malignant Neoplasm in the Central Nervous System — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Patient and Caregiver Priorities in Neuro-oncology Care NCT06676306	Mayo Clinic	—
Terminated	E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic NCT05388877	Mayo Clinic	Phase 1
Recruiting	CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma NCT04870944	Children's Oncology Group	Phase 1 / Phase 2
Completed	An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors NCT04539574	M.D. Anderson Cancer Center	N/A
Active Not Recruiting	WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Centr NCT04197934	Mayo Clinic	Phase 1
Withdrawn	Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Ca NCT03868423	Sameek Roychowdhury	Phase 2
Completed	Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbon NCT03565367	Daniel M. Spielman	Phase 1